Home › Funds › Principal Global Investors › VRTX
Principal Global Investors position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)389.51K sh
Reported value held$193.48M
Portfolio Weight0.10%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 320.05K | $58.05M | New |
| Q4 2021 | 306.31K | $67.27M | Reduce |
| Q1 2022 | 300.84K | $78.51M | Reduce |
| Q2 2022 | 316.43K | $89.17M | Add |
| Q3 2022 | 356.16K | $103.12M | Add |
| Q4 2022 | 331.12K | $95.62M | Reduce |
| Q1 2023 | 333.59K | $105.10M | Add |
| Q2 2023 | 330.94K | $116.46M | Reduce |
| Q3 2023 | 328.72K | $114.31M | Reduce |
| Q4 2023 | 368.73K | $150.03M | Add |
| Q1 2024 | 363.14K | $151.79M | Reduce |
| Q2 2024 | 388.71K | $182.20M | Add |
| Q3 2024 | 410.36K | $190.85M | Add |
| Q4 2024 | 396.53K | $159.68M | Reduce |
| Q1 2025 | 414.37K | $200.90M | Add |
| Q2 2025 | 409.81K | $182.45M | Reduce |
| Q3 2025 | 406.50K | $159.20M | Reduce |
| Q4 2025 | 415.10K | $188.19M | Add |
| Q1 2026 | 426.52K | $190.46M | Add |
| Q2 2026 | 389.51K | $193.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026